Optimization of a multicomponent intervention to foster functional recovery after breast cancer treatment

Active Grant Awarded

Award ID
R01CA299858
Recipient
Awarding agency
Obligated
$696,498

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 12% complete
Place of performance
Charlestown, MA 02129, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded The MGH Institute of Health Professions, Inc. $696,498 on April 13, 2026, under Grant R01CA299858 in the Cancer Cause and Prevention Research program (CFDA 93.393). The award funds an optimization trial of a multicomponent intervention to foster functional recovery and participation in life roles among breast cancer survivors after treatment. The recipient will test three remotely delivered components, priority elicitation, education, and guided application involving goal setting, problem-solving, and action planning, using a 2³ factorial design that randomizes 352 breast cancer survivors to eight conditions. Aim 1 tests main effects and interactions among the components, and Aim 2 evaluates mechanisms of action on proximal targets. The objective is an intervention package ready for efficacy testing. The period of performance ends April 30, 2031, and the place of performance is Charlestown, MA 02129.

Three sub-recipients share the work. The University of Alabama at Birmingham, awarded June 29, 2026, will test four telephone-delivered intervention components with 300 breast cancer survivors reporting participation restrictions in the first year after treatment. Dartmouth-Hitchcock Clinic, awarded July 4, 2026, will provide site principal investigator oversight, interventionist training, fidelity monitoring of two sessions from 15% of participants in each condition (90 sessions), and recruitment of a minimum of 50 participants from Dartmouth Cancer Center. The University of South Alabama, awarded September 14, 2026, will provide site oversight at the Mitchell Cancer Institute, project management, and a research coordinator responsible for recruiting a goal of 50 participants.

Description

Abstract
Almost one-third of breast cancer survivors report an inability to fully participate in vocational, social, physical, and instrumental activities of daily living. Breast cancer survivors who report lower participation in these activities report lower quality of life, greater depression, and are at risk for shortened survival. The long-term goal of this research is to address the absence of scalable, accessible, evidence-based interventions that improve cancer survivors' participation in life roles and activities. The objective of this R01 project is to systematically develop an intervention package ready for efficacy testing. We used the multiphase optimization strategy (MOST) framework to create a conceptual model of three remotely-delivered intervention components that have the potential to increase breast cancer survivors' engagement in role-relevant, valued activities: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning. The proposal will answer the research question: which of the intervention components, alone or in combination, MOST effectively reduce participation restrictions? We will conduct a MOST optimization trial using a 23 factorial design, randomizing 352 breast cancer survivors to one of eight conditions that offers a unique combination of the three intervention components. Aim 1 will test the main effects and interactions among the three components. Aim 2 will evaluate the mechanisms of action by testing the effect of each component on its hypothesized proximal target that can catalyze participation in social roles and activities. We hypothesize that priority elicitation will have the strongest effect on engagement in meaningful activities, education will have the strongest effect on self- efficacy for managing health and activity, and guided application will have the strongest effect on adaptive coping. Aim 3 will provide the analysis to assemble an optimized intervention package by evaluating the main effects and interactions using the following optimization criterion: the largest effect on participation restrictions. The approach is innovative because IT targets an area that reflects a priority of cancer survivors: helping them to find ways to fully and comfortably engage in the idiosyncratic activities that make life worth living. IT uses the MOST framework to better understand the mechanisms of action that can reduce participation restrictions. The project reflects not-OD-22-203 which calls for "systematic development… of behavioral interventions and their components" using "innovative…designs for building… and optimizing… interventions." the proposed research is significant because IT helps breast cancer survivors develop strategies to enhance productivity at home, in the workplace, and in the community, and to create sustainable lifestyle changes that foster health, participation, and functional well-being. As such, the knowledge gained from this study has the potential to advance the mission of the division of cancer control and population sciences of the national cancer institute by reducing disability and improving the quality of life of cancer survivors.

Subawards

Subrecipient Amount Awarded
University Of South Alabama SCOPE OF WORK Dr. Jennifer Pierce, MD, MPH (Site PI) will oversee all study activities at the USA Mitchell Cancer Institute (MCI). She will attend research… $39,559
Dartmouth-Hitchcock Clinic Performance Objectives: The Dartmouth-Hitchcock Clinic will: Dr. Stevens will - Participate in training interventionists and providing feedback regarding… $49,409
University Of Alabama At Birmingham Project Background and Need for Subaward We will test four telephone-delivered intervention components that we have used with breast cancer survivors: (1)… $213,589

Quick answers

Who received award R01CA299858?

R01CA299858 was awarded to The MGH Institute Of Health Professions, Inc. by National Cancer Institute (National Institutes of Health) on April 13, 2026.

How much is award R01CA299858 worth?

$696,498 has been obligated on R01CA299858.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award